Prudential Financial
NAGE

Prudential Financial’s Niagen Bioscience NAGE Stock Holding History

Prudential Financial’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-115,025
Closed -$732K – 2532
2025
Q4 		$732K Sell
115,025
-68,710
-37% -$478K ﹤0.01% 1713
2025
Q3 		$1.71M Buy
183,735
+49,889
+37% +$504K ﹤0.01% 1425
2025
Q2 		$1.93M Buy
133,846
+38,461
+40% +$380K ﹤0.01% 1401
2025
Q1 		$658K Buy
95,385
+16,170
+20% +$102K ﹤0.01% 1730
2024
Q4 		$420K Buy
79,215
+56,400
+247% +$309K ﹤0.01% 1893
2024
Q3 		$83.3K Hold
22,815
– – ﹤0.01% 2596
2024
Q2 		$62.3K Sell
22,815
-2,985
-12% -$9.99K ﹤0.01% 2593
2024
Q1 		$89.8K Hold
25,800
– – ﹤0.01% 2537
2023
Q4 		$36.9K Hold
25,800
– – ﹤0.01% 2577
2023
Q3 		$37.7K Hold
25,800
– – ﹤0.01% 2529
2023
Q2 		$40.5K Buy
+25,800
New +$38.5K ﹤0.01% 2553
2020
Q4 		– Sell
-29,000
Closed -$116K – 2511
2020
Q3 		$116K Buy
+29,000
New +$140K ﹤0.01% 2358

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Prudential Financial's NAGE Position: Q1 2026 in Review

Prudential Financial sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 115,025 shares — an estimated $732K sold.

Prudential Financial first reported a position in NAGE in Q3 2020 and held it in 12 quarters. The position peaked at $1.93M in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Prudential Financial reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Prudential Financial sold 115,025 Niagen Bioscience shares in Q1 2026, an estimated $732K.
  • Prudential Financial first reported a position in Niagen Bioscience in Q3 2020 and held it in 12 quarters.
  • Prudential Financial's Niagen Bioscience position peaked at $1.93M in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.